- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04761562
Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections
Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Otitis Media
This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma as a supplement to the surgical treatment of chronic tympanic membrane perforations.
Half of the participants will be treated with standard surgical procedure called tympanoplasty and addition of platelet- and extracellular vesicle-rich plasma. Another half will be treated with only the standard tympanoplasty.
Study Overview
Status
Intervention / Treatment
Detailed Description
The study is designed to be mono-centric, prospective, double-blind, parallel, uniformly randomised, controlled, with a fixed sample.
The purpose of the study is to determine whether autologous platelet- and extracellular vesicle-rich plasma (PVRP) made from peripheral venous blood, promotes healing of tympanic membrane perforations, improves hearing and quality of life after surgical procedure called tympanoplasty.
Tympanoplasty is a surgical procedure in which the surgeon refreshes the edges of the perforation of the eardrum and thus encourage re-healing of the eardrum. The tympanic membrane lies in the air, thus a tissue (muscle fascia, perichondrium, fat or cartilage) has to be put underneath the perforation and eardrum remnant. This then serves as a guide for the newly formed tympanic cells can outgrow the perforation.
Patients attending outpatient examinations will be included in the study if they meet the inclusion criteria. Included patients will be randomised in two groups.
Patients from the control group will be treated with a standard surgical treatment - tympanoplasty. The surgical procedure for the patients from the treatment group will be the same as for the control group, for the exception that PVRP will be added around the tympanic membrane remnant. PVRP will be activated inside (endogenous) and outside (exogenous) the body.
Postoperatively patients will be assessed at examinations using an endoscope, otomicroscope, Chronic otitis media questionnaire and tests of hearing and balance. Laboratory blood tests will determine the presence of possible inflammation and assess the composition of the preparation.
Research hypotheses
- Hypothesis 1: In the group of patients treated with platelet-rich plasma and extracellular vesicles, the proportion of healed tympanic surfaces in terms of initial perforation will be higher than in patients treated without platelet-rich plasma and extracellular vesicles.
- Hypothesis 2: In the group of patients treated with platelet-rich plasma and extracellular vesicles, complete healing of the tympanic membrane will occur to a greater extent than in patients treated without platelet-rich plasma and extracellular vesicles.
- Hypothesis 3: In the group of patients treated with platelet-rich plasma and extracellular vesicles, hearing improvement will be greater than in patients treated with platelet-rich plasma and extracellular vesicles.
- Hypothesis 4: The quality of life of patients with larger perforations assessed with the COMQ-12 questionnaire will be lower than in patients treated without platelet-rich plasma and extracellular vesicles.
- Hypothesis 5: The quality of life assessed by the COMQ-12 questionnaire will be better in the group of patients treated with platelet-rich plasma and extracellular vesicles than in patients treated without platelet-rich plasma and extracellular vesicles.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Nejc Steiner, MD
- Phone Number: +38615223280
- Email: nejc.steiner@kclj.si
Study Contact Backup
- Name: Saba Battelino, PhD, MD
- Phone Number: +38615228307
- Email: saba.battelino@kclj.si
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- University Medical Centre Ljubljana
-
Contact:
- Nejc Steiner, MD
- Phone Number: +38615223280
- Email: nejc.steiner@kclj.si
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- tympanic membrane,
- dry middle ear cavity,
- absence of exclusion criteria.
Exclusion Criteria:
- signs of cholesteatoma,
- anemia,
- thrombocytopenia,
- chronic use of immunomodulatory agents and / or antimicrobials,
- malignancy in the ear area,
- systemic infectious disease,
- autoimmune disease,
- inability and / or refusal of the patient to participate in the research,
- pregnancy and / or breast-feeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Control group
Patients will be treated with a standard surgical procedure - tympanoplasty.
|
Edges of the tympanic membrane perforation will be refreshed and the tympanomeatal flap raised.
Under the tympanic membrane perforation, a guide (fascia of the temporalis muscle, perichondrium, cartilage or fat) will be placed.
An absorbent gelatin sponge will be placed under the guide and on the outer surface of the reconstructed tympanic membrane.
Other Names:
|
EXPERIMENTAL: PVRP group
Patients will be treated with a standard surgical procedure - tympanoplasty combined with PVRP.
PVRP will be applied to the reconstructed tympanic membrane.
|
PVRP will initially be applied to the gelatine sponge without prior exogenous activation, which will first be inserted into the middle ear cavity to support the reconstructed tympanic membrane.
The remainder of the PVRP will then be exogenously activated with calcium chloride.
Gel rich with platelets and extracellular vesicles will be created and applied on top of the reconstructed tympanic membrane.
Finally, the external auditory canal will be filled with pieces of gelatine sponge soaked with PVRP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of tympanic membrane perforation size
Time Frame: Baseline (1 day pre-operatively), 6 weeks, 3 months and 6 months after surgery.
|
The size of the tympanic membrane perforation will be expressed as proportion of the total surface area of the tympanic membrane.
Number of pixels on an endoscopic photograph of the tympanic membrane will be measured with a computer program.
The measured number of perforation pixels will be divided by the measured number of pixels of the entire tympanic membrane.
The measurement will be performed by two doctors and the average value of the measured proportion of the drum surface used.
|
Baseline (1 day pre-operatively), 6 weeks, 3 months and 6 months after surgery.
|
Change in Chronic Otitis Media Questionnaire 12 score
Time Frame: Baseline (1 day pre-operatively), 6 months after surgery.
|
Sum score of Chronic Otitis Media Questionnaire 12 (COMQ-12), patient-reported health-related quality of life measure. Questionnaire consists of 12 questions, each question is scored from 0 to 5 points. |
Baseline (1 day pre-operatively), 6 months after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in hearing threshold level
Time Frame: Baseline (1 day pre-operatively), 6 weeks, 3 months and 6 months after surgery.
|
Pure tone audiometry will be done and pure tone average calculated from frequencies 125 to 8000 Herz.
|
Baseline (1 day pre-operatively), 6 weeks, 3 months and 6 months after surgery.
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Vozel D., Božič D., Jeran M., Jan Z., Pajnič M., Pađen L., Uršič B., Iglič A., Kralj-Iglič V., Battelino S. 2020. Treatment with platelet- and extracellular vesicle-rich plasma in otorhinolaryngology-a review and future perspectives. V Advances in Biomembranes and Lipid Self-Assembly. Academic Press. https://doi.org/10.1016/bs.abl.2020.05.003
- Vozel D, Steiner N, Bozanic Urbancic N, Mladenov D, Battelino S. Slovenian Cross-Cultural Adaptation and Validation of Health-Related Quality of Life Measures for Chronic Otitis Media (COMQ-12), Vertigo (DHI, NVI) and TINNITUS (THI). Zdr Varst. 2020 Jun 25;59(3):120-127. doi: 10.2478/sjph-2020-0016. eCollection 2020 Sep.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PVRPTY2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tympanic Membrane Perforation
-
Astellas Pharma Global Development, Inc.TerminatedChronic Tympanic Membrane PerforationUnited States
-
Cook Research IncorporatedRecruiting
-
Abd-Elazeem Abd-Elhameed ElbakryCompletedTympanum; PerforationEgypt
-
University of British ColumbiaCompleted
-
Central Adelaide Local Health Network IncorporatedUniversity of AdelaideRecruitingSurgery | Otitis Media | Tympanic Membrane Perforation | Tympanic Membrane InflammationAustralia
-
Assiut UniversityUnknownTympanic Membrane Perforation
-
Dr. Bradley WellingUnited States Department of DefenseCompletedTympanic Membrane PerforationUnited States
-
Mohammad Sadegh Bagheri BaghdashtCompletedTympanic Membrane Perforation
-
Assiut UniversityUnknownTympanic Membrane Perforation
-
University of PittsburghDepartment of Pediatric OtolaryngologyTerminatedTympanic Membrane PerforationUnited States
Clinical Trials on Control group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Henan Cancer HospitalRecruitingChemotherapy | Immune Checkpoint Inhibitor | Locally Advanced Gastric CarcinomaChina
-
International University of La RiojaRecruiting
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Physicians Committee for Responsible MedicineMetropolitan Police Department of Washington, D.C.SuspendedDiabetes Mellitus, Type 2 | Overweight | Blood PressureUnited States
-
University of PernambucoUnknown
-
Yonsei UniversityUnknownAdvanced Gastric Cancer | Neoadjuvant Chemotherapy | Palliative ChemotherapyKorea, Republic of
-
Istanbul University - Cerrahpasa (IUC)Active, not recruiting